StoneX Group Inc. Makes New Investment in SPDR S&P Biotech ETF (NYSEARCA:XBI)

StoneX Group Inc. purchased a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 4th quarter, Holdings Channel.com reports. The fund purchased 26,115 shares of the exchange traded fund’s stock, valued at approximately $2,352,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of XBI. Mirae Asset Securities USA Inc. boosted its position in shares of SPDR S&P Biotech ETF by 66.7% in the fourth quarter. Mirae Asset Securities USA Inc. now owns 1,500,000 shares of the exchange traded fund’s stock worth $135,090,000 after purchasing an additional 600,000 shares during the period. Proficio Capital Partners LLC boosted its holdings in SPDR S&P Biotech ETF by 16,156.1% in the 4th quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock worth $82,615,000 after buying an additional 911,686 shares during the period. Raymond James Financial Inc. purchased a new stake in SPDR S&P Biotech ETF in the 4th quarter worth $55,529,000. Clearbridge Investments LLC raised its holdings in SPDR S&P Biotech ETF by 20.5% during the fourth quarter. Clearbridge Investments LLC now owns 571,664 shares of the exchange traded fund’s stock valued at $51,484,000 after acquiring an additional 97,401 shares during the period. Finally, Whittier Trust Co. lifted its position in shares of SPDR S&P Biotech ETF by 3.1% in the fourth quarter. Whittier Trust Co. now owns 320,740 shares of the exchange traded fund’s stock valued at $28,885,000 after acquiring an additional 9,713 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 3.6 %

NYSEARCA XBI opened at $78.16 on Wednesday. SPDR S&P Biotech ETF has a 12 month low of $77.80 and a 12 month high of $105.47. The stock’s 50 day moving average is $89.02 and its 200 day moving average is $93.62. The stock has a market cap of $4.93 billion, a PE ratio of 11.47 and a beta of 1.00.

SPDR S&P Biotech ETF Cuts Dividend

The company also recently declared a dividend, which was paid on Wednesday, March 26th. Shareholders of record on Monday, March 24th were issued a dividend of $0.0053 per share. The ex-dividend date of this dividend was Monday, March 24th.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.